down arrow

Shanghai ZJ Bio-Tech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005DB6
CNY
20.31
0.2 (0.99%)

Dec 18

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai ZJ Bio-Tech Co., Ltd.
Why is Shanghai ZJ Bio-Tech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -32.14% and Operating profit at -187.84% over the last 5 years
2
The company has declared Negative results for the last 11 consecutive quarters
  • INTEREST(HY) At CNY 0.54 MM has Grown at 216.22%
  • OPERATING CASH FLOW(Y) Lowest at CNY 63.3 MM
  • PRE-TAX PROFIT(Q) At CNY -15.42 MM has Fallen at -149.06%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 17.88%, its profits have fallen by -14.6%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shanghai ZJ Bio-Tech Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shanghai ZJ Bio-Tech Co., Ltd.
17.88%
0.96
42.65%
China Shanghai Composite
15.14%
1.04
14.52%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-32.14%
EBIT Growth (5y)
-187.84%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.76
Sales to Capital Employed (avg)
0.12
Tax Ratio
13.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
69.93%
ROE (avg)
12.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.29
EV to EBIT
-6.56
EV to EBITDA
-8.32
EV to Capital Employed
2.20
EV to Sales
13.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.56%
ROE (Latest)
-4.74%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET PROFIT(HY)

Higher at CNY -130.47 MM

RAW MATERIAL COST(Y)

Fallen by -44.14% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -76.1 %

-32What is not working for the Company
INTEREST(HY)

At CNY 0.54 MM has Grown at 216.22%

OPERATING CASH FLOW(Y)

Lowest at CNY 63.3 MM

PRE-TAX PROFIT(Q)

At CNY -15.42 MM has Fallen at -149.06%

NET PROFIT(Q)

At CNY -16.02 MM has Fallen at -159.53%

NET SALES(Q)

Lowest at CNY 30.16 MM

Here's what is working for Shanghai ZJ Bio-Tech Co., Ltd.
Debt-Equity Ratio
Lowest at -76.1 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -44.14% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai ZJ Bio-Tech Co., Ltd.
Interest
At CNY 0.54 MM has Grown at 216.22%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 30.16 MM has Fallen at -39.01%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY -15.42 MM has Fallen at -149.06%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -16.02 MM has Fallen at -159.53%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY 63.3 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 30.16 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."